Yoo Wanho, Kim Saerom, Kim Soohan, Jeong Eunsuk, Lee Kwangha
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.
Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
Acute Crit Care. 2022 Feb;37(1):53-60. doi: 10.4266/acc.2021.01389. Epub 2022 Feb 22.
This study aimed to investigate the association between the Korean National Health Insurance coverage benefit extension policy and clinical outcomes of patients who were ventilated owing to various respiratory diseases.
Data from 515 patients (male, 69.7%; mean age, 69.8±12.1 years; in-hospital mortality rate, 28.3%) who were hospitalized in a respiratory intensive care unit were retrospectively analyzed over 5 years.
Of total enrolled patients, 356 (69.1%) had one benefit items under this policy during their hospital stay. They had significantly higher medical expenditure (total: median, 23,683 vs. 12,742 U.S. dollars [USD], P<0.001), out-of-pocket (median, 5,932 vs. 4,081 USD; P<0.001), and a lower percentage of out-of-pocket medical expenditure relative to total medical expenditure (median, 26.0% vs. 32.2%; P<0.001). Patients without benefit items associated with higher in-hospital mortality (hazard ratio [HR], 2.794; 95% confidence interval [CI], 1.980-3.941; P<0.001). In analysis of patients with benefit items, patients with three items ("cancer," "tuberculosis," and "disability") had significantly lower out-of-pocket medical expenditure (3,441 vs. 6,517 USD, P<0.001), and a lower percentage of out-of-pocket medical expenditure relative to total medical expenditure (17.2% vs. 27.7%, P<0.001). They were associated with higher in-hospital mortality (HR, 3.904; 95% CI, 2.533-6.039; P<0.001).
Our study showed patients with benefit items had more medical resources and associated improved in-hospital survival. Patients with the aforementioned three benefit items had lower out-of-pocket medical expenditure due to the implementation of this policy, but higher in-hospital mortality.
本研究旨在调查韩国国民健康保险覆盖福利扩展政策与因各种呼吸系统疾病接受通气治疗患者的临床结局之间的关联。
对5年间在呼吸重症监护病房住院的515例患者(男性占69.7%;平均年龄69.8±12.1岁;住院死亡率28.3%)的数据进行回顾性分析。
在所有登记患者中,356例(69.1%)在住院期间有一项该政策下的福利项目。他们的医疗支出显著更高(总计:中位数,23,683美元对12,742美元[USD],P<0.001),自付费用(中位数,5,932美元对4,081美元;P<0.001),且自付医疗支出占总医疗支出的百分比更低(中位数,26.0%对32.2%;P<0.001)。没有福利项目的患者住院死亡率更高(风险比[HR],2.794;95%置信区间[CI],1.980 - 3.941;P<0.001)。在对有福利项目的患者进行分析时,有三项福利项目(“癌症”、“结核病”和“残疾”)的患者自付医疗支出显著更低(3,441美元对6,517美元,P<0.001),且自付医疗支出占总医疗支出的百分比更低(17.2%对27.7%,P<0.001)。他们与更高的住院死亡率相关(HR,3.904;95%CI,2.533 - 6.039;P<0.001)。
我们的研究表明,有福利项目的患者拥有更多医疗资源且住院生存率有所提高。由于该政策的实施,有上述三项福利项目的患者自付医疗支出更低,但住院死亡率更高。